Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000384631 | SCV000331787 | uncertain significance | not provided | 2017-02-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000384631 | SCV001153325 | uncertain significance | not provided | 2017-04-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000384631 | SCV001818400 | uncertain significance | not provided | 2021-03-04 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Genetic Services Laboratory, |
RCV001726084 | SCV002067957 | likely benign | not specified | 2020-04-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000384631 | SCV002383160 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000384631 | SCV002542014 | uncertain significance | not provided | 2018-12-10 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000384631 | SCV001927490 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001726084 | SCV001964302 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003930041 | SCV004743451 | likely benign | SPEG-related disorder | 2019-05-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |